There were differences in FGA mRNA expression among different stages of liver cancer, and when we divided liver cancer into early (I and II) and late (III and IV) stages, FGA mRNA expression was significantly lower in late-stage liver cancer, indicating that FGA undergoes significant changes with the progression of liver cancer (P = 0.00066) (Figure 2H). The gene discussed is FGA; the disease is liver cancer.